Cytotoxic effects of TGF-α-Pseudomonas exotoxin A fusion protein in human pancreatic carcinoma cells

Pancreas

Volumn 13, Issue 1, 1996, Pages 16-21

  Baldwin, Rae Lynn ^a,c   Kobrin, Michael S ^a   Tran, Trang ^a   Pastan, Ira ^b   Korc, Murray ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Epidermal growth factor receptor; Growth inhibition; TP40

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EXOTOXIN; HYBRID PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CHO CELL; CYTOTOXICITY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PSEUDOMONAS AERUGINOSA; TUMOR CELL CULTURE;

EID: 0029937515     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199607000-00002     Document Type: Article

References (36)

1. Gudjonsson B. Cancer of the pancreas. 50 years of surgery. Cancer 1987;60:2284-303.
2. Warshaw AL, Ferandez-Del Castillo C. Pancreatic carcinoma. N Engl J Med 1992;326:455-65.
3. Korc M, Chandrasekar B, Yamanaka Y, Friess H, Büchler M, Beger HG. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J Clin Invest 1992; 90:1352-60.
4. Kobrin MS, Funatomi H, Friess H, Büchler MW, Stathis P, Korc M. Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem Biophys Res Commun 1994;202:1705-9.
5. Ebert M, Yokoyama M, Kobrin MS, et al. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res 1994;54:3959-62.
6. Yamanaka Y, Friess H, Kobrin MS, Büchler M, Beger HG, Korc M. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res 1993;13: 565-9.
7. Munehiro Y, Ebert M, Funatomi H, et al. Amphiregulin is a potent nitrogen in human pancreatic cancer cells: correlation with patient survival. Int J Oncol 1995;6:625-31.
8. Gray GL, Smith DL, Baldridge JS, et al. Cloning, nucleotide sequence and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 1984;81:2645-9.
9. Wick MJ, Frank DW, Storey DG, Iglewski BH. Structure, function, and regulation of Pseudomonas aeruginosa exotoxin A. Annu Rev Micro 1990;44:335-63.
10. Farahbakhsh ZT, Baldwin RL, Wisnieski BJ. Pseudomonas exotoxin A: membrane binding, insertion and traversal. J Biol Chem 1986;261:11404-8.
11. Pastan I, FitzGerald DJ. Pseudomonas exotoxin: chimeric toxins. J Biol Chem 1989;264:15157-60.
12. Kondo T, FitzGerald DJ, Chaudhary VK, Adhya S, Pastan I. Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain. J Biol Chem 1988;263:9470-5.
13. Heimbrook DC, Stirdivant SM, Ahern JD, et al. Transforming growth faclor-α-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing xenografts. Proc Natl Acad Sci USA 1990;87:4697-701.
14. Chaudhary VK, FitzGerald DJ, Adhya S, Pastan I. Activity of a recombinant fusion protein between transforming growth factor type a and Pseudomonas toxin. Proc Natl Acad Sci USA 1987;84:4538-42.
15. Siegall CB, Xu Y-H, Chaudhary VK, Adhya S, FitzGerald DJ, Pastan I. Cytotoxic activities of a fusion protein comprised of TGF-α and Pseudomonas exotoxin. FASEB J 1989;3:2647-52.
16. Korc M, Meltzer P, Trent J. Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer. Proc Natl Acad Sci USA 1986;83:5141-4.
17. Korc M, Chandrasekar B, Shah GN. Differential binding and biological activities of epidermal growth factor and transforming growth factor a in a human pancreatic cancer cell line. Cancer Res 1991;51:6243-9.
18. Moriai T, Kobrin MS, Hope C, Speck L, Korc M. A variant epidermal growth factor receptor exhibits altered type a transforming growth factor binding and transmembrane signaling. Proc Natl Acad Sci USA 1994;91:10217-21.
19. Chomczynski P, Sacchi N. Single-step RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
20. McCormick F, Trahey M, Innis M, Dieckmann B, Ringold G. Inducible expression of amplified human beta interferon genes in CHO cells. Mol Cell Biol 1984;4:166-72.
21. Korc M, Finman JE. Attenuated processing of epidermal growth factor in the face of marked degradation of transforming growth factor-α. J Biol Chem 1989;264:14990-9.
22. Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci 1949;5:660-72.
23. Munson PJ, Robard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980;107:220-39.
24. Green LM, Reade JL, Ware CF. Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Methods 1984;70:257-68.
25. Mossmann PB, Young LL. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:49-53.
26. Gerlier D, Thomasset N. Use of MTT colorimetric assay to measure cell activation. J Immunol Methods 1986;94:57-63.
27. Pai LH, Gallo MG, FitzGerald DJ, Pastan I. Antitumor activity of a transforming growth factor α-Pseudomonas exotoxin fusion protein (TP40). Cancer Res 1991;51:2808-12.
28. Liberman TA, Razon N, Bartal AD, Yarden Y, Schlessinger J, Soreq H. Expression of epidermal growth factor receptors in human brain tumors. Cancer Res 1984;44:753-60.
29. Ro J, North S, Gallick GE, Hortobagyi GN, Gutterman JU, Blick M. Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma. Cancer Res 1987;48:161-4.
30. Neal DE, Bennet MK, Hall RR, et al. Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet 1985;1:366-8.
31. Lau JL, Fowler JE Jr, Ghosh L. Epidermal growth factor in the normal and neoplastic kidney and bladder. J Urol 1988; 139:170-5.
32. Veale D, Kerr N, Gibson GJ, Harris AL. Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. Cancer Res 1989;49:1313-7.
33. Steck PA, Lee P, Hung M-C, Gelmann EP. Role of transforming growth factor-α in human prostate cancer cell growth. Prostate 1989;15:1-12.
34. 6]-leutinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma. Cancer Res 1990;50:1841-6.
35. Smith JJ, Derynck R, Korc M. Production of transforming growth factor a in human pancreatic cancer cells: evidence for a superagonist autocrine cycle. Proc Natl Acad Sci USA 1987;84:7567-70.
36. Epstein SE, Siegall CB, Biro S, Fu M, FitzGerald DJ, Pastan I. Cytotoxic effects of a recombinant chimeric toxin on rapidly proliferating vascular smooth muscle cells. Circulation 1991;84:778-87.